RareCyte

company

About

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

  • 11 - 50

Details

Last Funding Type
Series G
Last Funding Money Raised
$24M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's ground-breaking AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$24M
RareCyte has raised a total of $24M in funding over 2 rounds. Their latest funding was raised on Sep 9, 2021 from a Series G round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 9, 2021 Series G $24M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
RareCyte is funded by 1 investors. Agilent Technologies are the most recent investors.
Investor Name Lead Investor Funding Round
Agilent Technologies Series G